# Trem-1 and Ultraviolet Radiation-induced Immune Suppression

> **NCT05020496** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 70 (estimated)

## Conditions studied

- Skin Diseases

## Interventions

- **DRUG:** Diphenylcyclopropenone (DPCP)

## Key facts

- **NCT ID:** NCT05020496
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-21
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020496, "Trem-1 and Ultraviolet Radiation-induced Immune Suppression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05020496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*